Members

Leaders upholding cancer research policy and investment for Canada

The Canadian Health Research Forum comprised of Canadian leaders in cancer research, was formed in 2020 out of concern for the potential impacts of new federal regulations on Canada’s biomedical research ecosystem. Ultimately, the CHRF’s goal is to advocate for a policy environment that supports sustained public and private sector research investments and contributes to a world-leading health research ecosystem, for the benefit of Canadians and our knowledge economy. 

Members of CHRF include:

Richard Fajzel
M.B.A

CEO, Exactis Innovation
Chairman, Board of Directors CQDM

Dr. Gerald Batist MDCM, CM, CQ, FRCP(C), FACP, FAHC

Director, Segal Cancer Centre, Jewish General Hospital and McGill Centre for Translational Research in Cancer

Barry Stein
B.Comm, B.C.L., LL.B

President, Colorectal Cancer Canada
President, Coalition Priorité Cancer au Québec. Founder member, CPAC National Colorectal Cancer Screening Network

Rafi Hofstein
PhD

Past President and CEO MARs Innovation/TiAP (2009-2019)
Member of the Board of Directors, Exactis Innovation

Diane Gosselin
PhD, M.B.A.

President and CEO, CQDM

Laszlo G. Radvanyi
PhD

Professor, Department of Immunology, University of Toronto

Stephanie Michaud
PhD

President and Chief Executive Officer BioCanRx

Aaron Schimmer
MD, PhD, FRCPC

Staff Physician and Senior Scientist at the Princess Margaret Cancer Centre, University Health Network. Director of Research, Princess Margaret Cancer Centre. Professor, Department of Medical Biophysics, University of Toronto
Co-leader of OICR’s Acute Leukemia Translational Research Initiative

Rodney Ouellette
MD, PhD

Founding Scientific Director, the Atlantic Cancer Research Institute (ACRI)
Associate Professor, Department of Biochemistry, Université de Moncton
Scientific Director, Vitalité Health Network

Dr. David Malkin
MD, FRCP(C)

Senior Staff Oncologist, Division of Haematology/Oncology at the Hospital for Sick Children (SickKids)